Multus Biotechnology
PrivateLast Round
Series A
Jan 16, 2023
Total Funding Raised
$9.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Multus Biotechnology operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in January 2023.
Multus Biotechnology is a biotechnology company that develops and supplies animal-free cell culture media for the cultivated meat and cell therapy industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Multus Biotechnology Comparables
Compare Multus Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MarraBio | 87% | |
| Sticta Biologicals | 84% | |
| Deco Labs | 84% |
For institutional investors. Book with your work email.
Multus Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 16, 2023 | ||||
| Seed | Jul 27, 2021 | ||||
| Accelerator | Jun 11, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Multus Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Marinya Capital | Seed |
| SynBioVen | Series A |
| Innovate UK | Series A |
| IndieBio | Accelerator |
| Mandi Ventures | Series A |
| Big Idea Ventures | Series A |
| SOSV | Seed, Series A, Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 84% MoM.
- Jan 27, 2026
Added Imperial Enterprise, a biotechnology company, as a customer.
For institutional investors. Book with your work email.
Multus Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Multus Biotechnology's valuation, stock price, and market status.
Is Multus Biotechnology a public or private company?
Multus Biotechnology is a private company.
What is the current stock price of Multus Biotechnology?
Multus Biotechnology is a private company, so its shares have no public market price. Caplight tracks Multus Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Multus Biotechnology worth (valuation)?
Valuation information for Multus Biotechnology is not publicly available.
Can I buy Multus Biotechnology stock?
Multus Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Multus Biotechnology's last funding round?
Multus Biotechnology's most recent funding round was Series A on January 16, 2023.
Who are the main investors in Multus Biotechnology?
Key investors in Multus Biotechnology include Mandi Ventures.
Will Multus Biotechnology IPO soon?
No public IPO plans have been announced for Multus Biotechnology.
How can I track Multus Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Multus Biotechnology's shares on secondary markets.